Association of IL-18 promoter polymorphism with liver disease severity in HCV-infected patients

Hepatology International

Volumn 3, Issue 2, 2009, Pages 371-377

  Manohar, K ^a   Suneetha, P V ^a   Sukriti, ^a   Pati, Nirupama Trehan ^a   Gupta, Abhishek C ^a   Hissar, Syed ^a   Sakhuja, Puja ^a   Sarin, S K ^a  

^a G B PANT HOSPITAL   (India)

Author keywords

Fibrosis; HAI; Hepatitis C; IL 18; Polymorphism

Indexed keywords

INTERLEUKIN 18; VIRUS DNA; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA EXTRACTION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SCORING SYSTEM; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 65049083114     PISSN: 19360533     EISSN: 19360541     Source Type: Journal    
DOI: 10.1007/s12072-009-9127-0     Document Type: Article

References (32)

1. Lechmann M, Liang TJ. Vaccine development for hepatitis C. Semin Liver Dis 2000;20(2):211-226. doi: 10.1055/s-2000-9947
2. Hill AV. Genetics and genomics of infectious disease susceptibility. Br Med Bull 1999;55(2):401-413. doi: 10.1258/0007142991902457
3. Goyal A, Syed K, Sakhuja P, Malhotra V, Arora N, Sarin SK. Association of TNF-β polymorphism with disease severity among patients infected with hepatitis C virus. J Med Virol 2004;72:60-65. doi: 10.1002/jmv.10533
4. Zecchina D, Novick M, Rubinstein V, Barak C, Dinarello H, Nagler A. Interleukin-18 binding protein in acute graft versus host disease and engraftment following allogeneic peripheral blood stem cell transplants. J Hematother Stem Cell Res 2001;10(6):769-776. doi: 10.1089/ 152581601317210863
5. Kieszko R, Krawczyk P, Jankowska O, Chocholska S, Krol A, Milanowski J. The clinical significance of interleukin 18 assessment in sarcoidosis patients. Respir Med 2006;101(4):722-728. doi: 10.1016/j.rmed.2006.08.019
6. Kaser D, Novick M, Rubeinstein B, Siegmund B, Enrich RO, Koch W, et al. Interferon-α induces interleukin-18 binding protein in chronic hepatitis C patients. Clin Exp Immunol 2002;129(2):332-338. doi: 10.1046/ j.1365-2249.2002.01911.x
7. Asakawa M, Kono H, Amemiya H, Matsuda M, Suzuki T, Maki A, et al. Role of interleukin-18 and its receptor in hepatocellular carcinoma associated with hepatitis C virus infection. Int J Cancer 2006;118(3):564-570. doi: 10.1002/ijc.21367
8. Yasuhiko K, Tomoaki H, Okamoto M, Kato S, Koda Y, Nagata N, et al. Enhanced expression of interleukin-18 and its receptor in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 2004;31(6):619-625. doi: 10.1165/rcmb.2003-0306OC
9. Zhang PA, Wu JM, Li Y, Yang XS. A general method for nested RT-PCR amplification and sequencing the complete HCV genotype 1 open reading frame. Virol J 2005;2:88. doi: 10.1186/1743-422X-2-88
10. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV. Interleukin-18 inhibits hepatitis B virus replication in the livers of transgenic mice. J Virol 2002;76(21):10702-10707. doi: 10.1128/JVI.76.21.10702-10707.2002
11. Glas J, Torok HP, Tonenchi L, Kapser J, Schiemann U, Muller-Myhsok B, et al. Association of polymorphisms in the interleukin-18 gene in patients with Crohn's disease depending on the CARD15/NOD2 genotype. Inflamm Bowel Dis 2005;11(12):1031-1037. doi: 10.1097/01.MIB.0000187574.41290.b1
12. Tiret L, Godefroy T, Lubos E, Nicaud V, Tregouet DA, Barbaux S, et al. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 2005;112(5):643-650. doi: 10.1161/CIRCULATIONAHA.104.519702
13. Segat L, Bevilacqua D, Boniotto M, Arraes LC, de Souza PR, de Lima Filho JL, et al. IL-18 gene promoter polymorphism is involved in HIV-1 infection in a Brazilian pediatric population. Immunogenetics 2006;58(5-6):471-473
14. Goodman ZD, Ishak KG. Histopathology of hepatitis C virus infection. Semin Liver Dis. 1995;15(1):70-81, Review
15. Garson JA, Tuke PW, Makris M, Briggs M, Machin SJ, Preston FE, et al. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates. Lancet 1990;336(8722):1022-1025. doi: 10.1016/0140-6736(90)92487-3
16. Johns MB, Paulus-Thomas JE. Purification of human genomic DNA from whole blood using sodium perchlorate in place of phenol. Anal Biochem 1989;180(2):276-278. doi: 10.1016/0003-2697(89)90430-2
17. Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: A possible role of polymorphisms in expression regulation. J Neuroimmunol 2001;112:146-152. doi: 10.1016/ S0165-5728(00)00407-0
18. Togbe D, Aurore G, Noulin N, Quesniaux VF, Schnyder-Candrian S, Schnyder B, et al. Nonredundant roles of TIRAP and MyD88 in airway response to endotoxin, independent of TRIF, IL-1 and IL-18 pathways. Lab Invest 2006;86(11):1126-1135
19. Negishi H, Fujita Y, Yanai H, Sakaguchi S, Ouyang X, Shinohara M, et al. Evidence for licensing of IFN-gamma-induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proc Natl Acad Sci USA 2006;103(41):15136-15141. doi: 10.1073/pnas.0607181103
20. Abraham M, Shapiro S, Lahat N, Miller A. The role of IL-18 and IL-12 in the modulation of matrix metalloproteinases and their tissue inhibitors in monocytic cells. Int Immunol 2002;14(12):1449-1457. doi: 10.1093/ intimm/dxf108
21. Falasca K, Ucciferri C, Dalessandro M, Zingariello P, Mancino P, Petrarca C, et al. Cytokine patterns correlate with liver damage in patients with chronic hepatitis B and C. Ann Clin Lab Sci 2006;36(2):144-150
22. Murata K, Yamamoto N, Kawakita T, Saito Y, Yamanaka Y, Sugimoto K, et al. Up-regulation of IL-18 by interferon alpha-2b/ribavirin combination therapy induces an anti-viral effect in patients with chronic hepatitis C. Hepatogastroenterology 2005;52(62):547-551
23. Robertson MJ, Mier JW, Logan T, Atkins M, Koon H, Koch KM, et al. Clinical and biological effects of recombinant human interleukin-18 administered by intravenous infusion to patients with advanced cancer. Clin Cancer Res 2006;12(14):4265-4273
24. Pawlik A, Kurzawski M, Czerny B, Gawronska-Szklarz B, Drozdzik M, Herczynska M. Interleukin-18 promoter polymorphism in patients with rheumatoid arthritis. Tissue Antigens. 2006;67(5):415-418
25. Mojtahedi Z, Naeimi S, Farjadian S, Omrani GR, Ghaderi A. Association of IL-18 promoter polymorphisms with predisposition to Type 1 diabetes. Diabet Med. 2006;23(3):235-239
26. Boraska V, Terzić J, Skrabić V, Cać ev T, Bucević-Popović V, Peruzović M, et al. NeuroD1 gene and interleukin-18 gene polymorphisms in type 1 diabetes in Dalmatian population of Southern Croatia. Croat Med J. 2006;47(4):571-578
27. Lee HM, Park SA, Chung SW, Woo JS, Chae SW, Lee SH, et al. Interleukin-18/607 gene polymorphism in allegic rhinitis. Int J Pediatric Otorhinoalaryngol. 2006;70(6):1085-1088
28. Jang WC, Park SB, Nam YH, Lee SS, Kim JW, Chang IS, et al. Interleukin-18 gene polymorphisms in Korean patients with Behç's disease. Clin Exp Rheumatol. 2005;23(4 Suppl 38):S59-S63
29. Zhou Y, Yamaguchi E, Fukui Y, Konno S, Maeda Y, Kimata K, et al. Enhanced expression of interleukin-18 receptor alpha chain by CD4+ T cells in sarcoidosis. Chest. 2005;128(4):2497-2503
30. Folwaczny M, Glas J, Török HP, Tonenchi L, Paschos E, Bauer B, et al. Polymorphisms of the interleukin-18 gene in periodontitis patients. J Clin Periodontol. 2005;32(5):530-534
31. Novak N, Kruse S, Potreck J, Maintz L, Jenneck C, Weidinger S, et al. Single nucleotide polymorphisms of IL-18 gene are associated with atopic eczema. J Allergy Clin Immunology. 2005;115(4):828-833
32. Aizawa Y, Sutoh S, Matsuoka M, Negishi M, Torii A, Miyakawa Y, et al. Association of interleukin-18 gene single nucleotide polymorphisms with susceptibility of inflammatory bowel disease. Tissue Antigens. 2005;65(1):88-92